Rothschild Investment LLC’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $23.3K | Buy |
1,390
+88
| +7% | +$1.48K | ﹤0.01% | 987 |
|
2025
Q1 | $20K | Sell |
1,302
-234
| -15% | -$3.6K | ﹤0.01% | 999 |
|
2024
Q4 | $33.9K | Sell |
1,536
-820
| -35% | -$18.1K | ﹤0.01% | 872 |
|
2024
Q3 | $42.5K | Buy |
2,356
+1,994
| +551% | +$35.9K | ﹤0.01% | 820 |
|
2024
Q2 | $5.88K | Buy |
362
+151
| +72% | +$2.45K | ﹤0.01% | 1179 |
|
2024
Q1 | $2.98K | Buy |
211
+24
| +13% | +$339 | ﹤0.01% | 1182 |
|
2023
Q4 | $1.95K | Buy |
+187
| New | +$1.95K | ﹤0.01% | 1148 |
|
2017
Q4 | – | Sell |
-16,577
| Closed | -$292K | – | 419 |
|
2017
Q3 | $292K | Sell |
16,577
-7,650
| -32% | -$135K | 0.03% | 345 |
|
2017
Q2 | $805K | Buy |
24,227
+15,357
| +173% | +$510K | 0.09% | 222 |
|
2017
Q1 | $285K | Buy |
8,870
+166
| +2% | +$5.33K | 0.03% | 358 |
|
2016
Q4 | $316K | Sell |
8,704
-8,689
| -50% | -$315K | 0.04% | 333 |
|
2016
Q3 | $800K | Buy |
17,393
+263
| +2% | +$12.1K | 0.1% | 199 |
|
2016
Q2 | $860K | Sell |
17,130
-500
| -3% | -$25.1K | 0.11% | 189 |
|
2016
Q1 | $943K | Hold |
17,630
| – | – | 0.12% | 182 |
|
2015
Q4 | $1.16M | Hold |
17,630
| – | – | 0.15% | 158 |
|
2015
Q3 | $995K | Hold |
17,630
| – | – | 0.13% | 177 |
|
2015
Q2 | $1.04M | Buy |
17,630
+140
| +0.8% | +$8.28K | 0.12% | 191 |
|
2015
Q1 | $1.09M | Hold |
17,490
| – | – | 0.13% | 175 |
|
2014
Q4 | $1.01M | Buy |
17,490
+6,689
| +62% | +$385K | 0.12% | 179 |
|
2014
Q3 | $581K | Buy |
10,801
+111
| +1% | +$5.97K | 0.07% | 272 |
|
2014
Q2 | $560K | Hold |
10,690
| – | – | 0.07% | 247 |
|
2014
Q1 | $565K | Sell |
10,690
-850
| -7% | -$44.9K | 0.08% | 248 |
|
2013
Q4 | $463K | Sell |
11,540
-700
| -6% | -$28.1K | 0.06% | 279 |
|
2013
Q3 | $462K | Hold |
12,240
| – | – | 0.07% | 262 |
|
2013
Q2 | $480K | Buy |
+12,240
| New | +$480K | 0.08% | 235 |
|